For the year ending 2025-12-31, INBX has $146,478K in assets. $138,485K in debts. $124,220K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 124,220 | |||
| Accounts receivable-Nonrelated Party | 0 | |||
| Other receivables | 177 | |||
| Accounts receivable-Related Party | 0 | |||
| Prepaid expenses and other current assets | 8,435 | |||
| Total current assets | 132,832 | |||
| Property and equipment, net | 3,733 | |||
| Operating right-of-use asset | 5,535 | |||
| Other non-current assets | 4,378 | |||
| Total assets | 146,478 | |||
| Accounts payable | 5,944 | |||
| Accrued expenses | 25,529 | |||
| Current portion of operating lease liability | 2,326 | |||
| Total current liabilities | 33,799 | |||
| Long-term debt, including final payment fee | 100,559 | |||
| Non-current portion of operating lease liability | 4,127 | |||
| Total liabilities | 138,485 | |||
| Common stock, 0.0001 par value, 120,000,000 shares authorized as of december31, 2025 and december31, 2024 14,577,609 and 14,475,904 shares issued and outstanding as of december31, 2025 and december31, 2024, respectively | 1 | |||
| Additional paid-in-capital | 254,179 | |||
| Accumulated deficit | -246,187 | |||
| Total stockholders equity | 7,993 | |||
| Total liabilities and stockholders equity | 146,478 | |||
Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX)